Targeting high-risk groups in the post-pandemic era: A focus on pediatric hematological malignancies
Saved in:
| Main Authors: | Nan-Chang Chiu, Hsin Chi, Chien-Yu Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Pediatrics and Neonatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957224001578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoint inhibitors in pediatric hematologic malignancies
by: I. V. Gribkova
Published: (2023-05-01) -
Molecular-Targeted Therapies for Hematologic Malignancies
by: Kevin D. Bunting, et al.
Published: (2012-01-01) -
Lysosome targeted therapies in hematological malignancies
by: Madhumita S. Manivannan, et al.
Published: (2025-02-01) -
Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies
by: Chengyun Pan, et al.
Published: (2025-06-01) -
Vancomycin therapeutic drug monitoring: focus on patients with hematological malignancies
by: Yifan Luo, et al.
Published: (2025-12-01)